Study Objective: To evaluate the efficacy of cisatracurium, rocuronium, and d-tubocurarine in preventing succinylcholine-induced fasciculations and postoperative myalgia in patients undergoing ambulatory surgery.
Subjects: 80 ASA physical status I and II patients scheduled for elective ambulatory surgery with general anesthesia.
Intervention: A standardized balanced anesthetic technique was used for all patients.
Measurements and Main Results: Patients were randomized to receive cisatracurium 0.01 mg/kg, rocuronium 0.06 mg/kg, d-tubocurarine 0.05 mg/kg, or saline, 3 minutes prior to intravenous (IV) succinylcholine 1.5 mg/kg. The intensity of fasciculations and intubating conditions were assessed using a four-point rating scale. In addition, the severity of myalgia was assessed using a four-point rating scale in the postanesthesia care unit and at 24 hours postoperatively. No patient complained of any side effects after the administration of the study drug. Fasciculations were observed less frequently (p < 0.05) in the d-tubocurarine and rocuronium groups compared with the placebo and cisatracurium groups. However, there was no difference between the d-tubocurarine group and the rocuronium group (21% vs. 10%, respectively). Although fasciculations occurred less frequently in the cisatracurium group than in the placebo group (59% vs. 85%, respectively), this difference did not reach statistical significance. There was no difference among the four groups in the intubating conditions or the incidence of postoperative myalgia.
Conclusion: Pretreatment with rocuronium and d-tubocurarine was superior to cisatracurium in preventing succinylcholine-induced fasciculations. However, pretreatment did not have any effect on the incidence of myalgia after ambulatory surgery. 相似文献
目的:通过乳酸脱氢酶(lactate dehydrogenase,LDH)的检测,观察解毒通络药物干预后的脑微血管内皮细胞条件培养液(conditioned medium of cerebral microvascular endothelial cells,CMECs-CM)特征及其抗缺血及再灌皮质神经元损伤的效应,探讨脑微血管内皮细胞(cerebral microvascular endothelial cells,CMECs)调控神经元功能的机制。方法:通络救脑注射液(Tongluo Jiunao Injection,TLJNI)作用于正常、缺血和缺血再灌三种培养状态的大鼠CMECs,分别收集有药物干预及无干预的三对无血清内皮细胞条件培养液,并测定其LDH值。同步原代培养大鼠脑皮质神经元,亦分为正常、缺血、缺血再灌三组,用低(10%)、中(50%)、高(100%)三种浓度的各类CMECs-CM分别作用上述三种培养状态的神经元,测定其LDH漏出率。结果:比较TLJNI干预后的CMECs-CM与无干预的CMECs-CM中LDH漏出值,CMECs缺血组与缺血再灌组经药物干预后均明显降低(P<0.01)。对于缺血神经元,缺血内皮细胞条件培养液(conditioned medium of ischemic CMECs,Is-CM)高浓度(100%)和TLJNI干预后的缺血内皮细胞条件培养液(conditioned medium of ischemic CMECs with drug treatment,IsT-CM)高浓度(100%)作用后表现为增加LDH漏出率(P<0.01),而低浓度10%的IsT-CM则降低LDH漏出率(P<0.05);对于缺血再灌神经元,与对照组比较,各类CMECs-CM作用后均能降低神经元LDH漏出率(P<0.05或P<0.01)。比较每种条件液相邻浓度间的效应差异,均以10%或50%的CM降低损伤为佳,正常内皮细胞条件培养液(conditioned medium of normal CMECs,N-CM)及缺血再灌内皮细胞条件培养液(conditioned medium of ischemic/reperfusional CMECs,Rp-CM)组间差异有统计学意义(P<0.05或P<0.01);对于正常神经元,各类CMECs-CM作用后均增加了神经元LDH漏出率(P<0.05或P<0.01)。比较每种条件液相邻浓度间的效应差异,N-CM组间差异有统计学意义(P<0.05或P<0.01)。结论:TLJNI能够防御CMECs缺血及缺血再灌的损伤,可以通过内皮细胞介导发挥抗缺血及缺血再灌神经元损伤的效应。提示CMECs-CM及TLJNI干预后的CMECs-CM均存在着抗缺血再灌神经元损伤的活性物质。 相似文献